HomeJapanAI Medical Service Raises US$70M in Series C Financing

AI Medical Service Raises US$70M in Series C Financing


AI Medical Service, a Tokyo, Japan-based med-tech company using deep learning technology to develop endoscopic AI, raised US$70M in Series C funding.

The round was led by SoftBank Vision Fund 2 (SVF2) with participation from Globis Capital Partners, World Innovation Lab (WiL), and Incubate Fund.

The company intends to use the funds for
1. Acceleration of global business development
РDriving joint research and product development with medical institutions in the U.S., Asia-Pacific region, etc.
– Acquiring the talent necessary to expand global business

2. Developing a proprietary cloud platform to eliminate GI cancer around the world
– Creating an in-house cloud platform that connects endoscopy rooms around the world to AIM’s endoscopic AI.

AI Medical Service (AIM) is a medtech company leading player in the field of cloud-based endoscopic AI, engaging in joint research with more than 100 medical institutions with the aim of bringing endoscopic AI to real-world clinical setting as soon as possible to reduce the number of missed cancer diagnoses and save lives.